Science Explorer Back to mapMap
Discussion
Topic · Infectious Diseases

Antimicrobial Resistance in Staphylococcus

Antimicrobial Resistance in Staphylococcus is a research topic within Infectious Diseases. Science Explorer counts 38k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, pathophysiology, clinical manifestations, management, and genetic analysis of Methicillin-Resistant Staphylococcus aureus (MRSA) infections. It covers topics such as antimicrobial resistance, virulence factors, vancomycin resistance, community-acquired and healthcare-associated infections.

  • MRSA
  • Staphylococcus aureus
  • Antimicrobial Resistance
  • Epidemiology
  • Clinical Management
  • Virulence Factors
  • Genetic Analysis
  • Vancomycin Resistance
  • Community-Acquired Infections
  • Healthcare-Associated Infections
Research works
38k
fractional, since 1950
In the world top 10%
3.9k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-6%
the tick is no change
Largest producer
United States
34% of the 10 largest, 2022-now
Antimicrobial Resistance in Staphylococcus

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Antimicrobial Resistance in Staphylococcus research?

By volume, the United States and China publish the most (1.3k and 750 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.3k works
  2. 2 China 750 works
  3. 3 India 393 works
  4. 4 Japan 263 works
  5. 5 Germany 218 works
  6. 6 France 211 works
  7. 7 United Kingdom 210 works
  8. 8 Spain 185 works
  9. 9 Italy 174 works
  10. 10 Brazil 166 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 34.2%China: 19.2%India: 10.1%Japan: 6.7%6 others listed: 29.8%34%largest
United States1,337 · 34.2%China750 · 19.2%India393 · 10.1%Japan263 · 6.7%6 others listed1,163 · 29.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Antimicrobial Resistance in Staphylococcus research?

By volume in 2022-now, Harvard University publishes the most Antimicrobial Resistance in Staphylococcus research, followed by Mayo Clinic and Zhejiang University.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 33 works
  2. 2 Mayo ClinicUnited States 28 works
  3. 3 Zhejiang UniversityChina 26 works
  4. 4 InsermFrance 25 works
  5. 5 Centre National de la Recherche ScientifiqueFrance 25 works
  6. 6 Shanghai Jiao Tong UniversityChina 24 works
  7. 7 Islamic Azad University, TehranIran 23 works
  8. 8 University of CopenhagenDenmark 21 works
  9. 9 The University of MelbourneAustralia 20 works
  10. 10 United States Department of Veterans AffairsUnited States 20 works

Who are the leading researchers in Antimicrobial Resistance in Staphylococcus?

The most-cited researchers publishing on Antimicrobial Resistance in Staphylococcus include Rob Knight, Elaine R. Mardis and Hermann Brenner.

  1. 1 Rob Knight United States 468k citations
  2. 2 Elaine R. Mardis United States 346k citations
  3. 3 Hermann Brenner Germany 343k citations
  4. 4 Shizuo Akira Japan 342k citations
  5. 5 Jun Wang China 340k citations
  6. 6 Gregory Y.H. Lip United Kingdom 311k citations
  7. 7 Richard A. Gibbs United States 292k citations
  8. 8 Michael Karin United States 276k citations
  9. 9 Heng Li United States 270k citations
  10. 10 Victoria Delgado Netherlands 269k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Antimicrobial Resistance in Staphylococcus?

The most cited paper in Antimicrobial Resistance in Staphylococcus is "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance" (Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al., 2011), with 14,554 citations. Next come "CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting" (6,712) and "Staphylococcus aureus Infections" (6,083).

Most cited papers
#PaperReleasedCitations
1 Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection Open access 7 May 2011 14,554
2 CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting Teresa C Horan, Mary L. Andrus, Margaret A. Dudeck · American Journal of Infection Control Jun 2008 6,712
3 Staphylococcus aureus Infections F D Lowy · New England Journal of Medicine 20 Aug 1998 6,083
4 Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management Steven Y. C. Tong, Joshua Saul Davis, Emily M. Eichenberger et al. · Clinical Microbiology Reviews Open access 27 May 2015 5,276
5 2015 ESC Guidelines for the management of infective endocarditis Gilbert Habib et al. · European Heart Journal Open access119 authors 29 Aug 2015 5,046
All 99 most cited papers, with filters and sorting

Where is Antimicrobial Resistance in Staphylococcus research done?

The largest centres of Antimicrobial Resistance in Staphylococcus research in 2022-now are Beijing (China), Tokyo (Japan), Shanghai (China) and Paris (France).

Largest cities, 2022-now

  1. 1 BeijingChina 107 works
  2. 2 TokyoJapan 72 works
  3. 3 ShanghaiChina 68 works
  4. 4 ParisFrance 68 works
  5. 5 SeoulSouth Korea 58 works
  6. 6 MadridSpain 58 works
  7. 7 LondonUnited Kingdom 55 works
  8. 8 New YorkUnited States 46 works
  9. 9 HangzhouChina 44 works
  10. 10 GuangzhouChina 44 works
See Antimicrobial Resistance in Staphylococcus on the map

Where is the best place to study Antimicrobial Resistance in Staphylococcus?

Among universities, judged by research, Harvard University, Zagazig University and University of Veterinary and Animal Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 16.81%fractional works in this field (log) →share of work in the world top 10% →Zagazig UniversityUniversity of Veteri…University of ZurichHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 66.412.1%1.9×33 -19.1%
2Zagazig UniversityEgypt 65.522.3%6.4×13 +60.7%
3University of Veterinary and Animal SciencesPakistan 65.520.8%24.0×8 +156.0%
4University of ZurichSwitzerland 63.015.7%3.5×13 +19.9%
5Mansoura UniversityEgypt 61.916.5%6.0×15 +28.1%
6Zhejiang UniversityChina 61.113.9%1.8×26 +44.5%
7The University of MelbourneAustralia 58.516.1%3.3×20 -30.4%
8Capital Medical UniversityChina 56.716.5%3.4×20 +59.7%
9Yangzhou UniversityChina 56.121.5%3.1×9 +143.5%
10University of CopenhagenDenmark 55.512.7%4.1×21 -19.0%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Antimicrobial Resistance in Staphylococcus, country by country

Is Antimicrobial Resistance in Staphylococcus research growing?

Output in 2022-2025 was 6% lower than in 2018-2021, peaking in 2020.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Antimicrobial Resistance in Staphylococcus as a percentage of every work published that year, 0.024% in 2024.

still counting0.020%0.040%0.060%Antimicrobial Resistance in Staphylococcus0.025% in 202519801990200020102020

Fractional works of Antimicrobial Resistance in Staphylococcus over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Antimicrobial Resistance in Staphylococcus10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Antimicrobial Resistance in Staphylococcus. Posts are plain text and can be reported.